This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Washington University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Michael P Rettig: Innovator in Cancer Treatment
Introduction
Michael P Rettig is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on enhancing the immune response in cancer cells, particularly in hematological cancers.
Latest Patents
Michael P Rettig holds a patent for "Methods and compositions for treatment of cancer." This patent outlines various methods and compositions aimed at upregulating MHC class II in cancer cells, specifically targeting hematological cancer cells. The patent also details treatment methods for subjects suffering from hematological cancers, which include the administration of interferon-γ (IFN-γ). These methods are particularly beneficial for patients who have undergone allogenic transplants or experienced relapses.
Career Highlights
Michael P Rettig is affiliated with Washington University, where he continues to advance his research in cancer treatment. His dedication to improving therapeutic options for cancer patients has positioned him as a key figure in the medical research community.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including John F Dipersio and Allegra Petti. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer treatments.
Conclusion
Michael P Rettig's contributions to cancer treatment through his patented methods demonstrate his commitment to advancing medical science. His work not only provides hope for patients but also paves the way for future innovations in cancer therapy.